Humans In Space

News

Boryung announces winners of the inaugural 2022 CIS Challenge

2022-11-17
<figure class='image image_resized' style='width:884px;'><img src='/img/DATA/attachFiles/file/Editor/2023/05/31/a8acce0e-eacd-4c72-b976-f78f1cfa84a0'><figcaption>(Photo: Six winners from the inaugural 2022 CIS Challenge)</figcaption></figure><p><br>On August 27, Boryung (CEO Jay Kim) announced the winner of the inaugural 2022 CIS (Care In Space) Challenge.</p><p>The CIS Challenge is a program that encourages startups from various fields, including medical devices, diagnostics, and pharmaceuticals, to discover an unexplored area of healthcare in space. Boryung has partnered with leading human spaceflight services provider Axiom Space and aerospace and defense innovation catalyst Starbust Aerospace.</p><p>Earlier this year, Boryung launched the first annual CIS Challenge to find solutions to various healthcare issues that may arise from long-term human activities in space, where microgravity prevails. Experts and practitioners with diverse backgrounds in space healthcare carefully selected the judging panel that evaluated the business model's creativity, scientific evidence, feasibility, and overall viability to determine the winners. The first event of the CIS Challenge was a Pitch Day held in Los Angeles on August 4 (local time).</p><p>The six winners of the inaugural 2022 CIS Challenge are Advanced TeleSensors, Deep Space Biology, Myelin-H, Nano PharmaSolutions, ViBo Health, and Xtory.</p><p>Advanced TeleSensors is building a non-intrusive cardiac monitor for remote patient monitoring that uses advanced radio frequencies to detect heart rate and breathing patterns without physical contact.</p><p>Deep Space Biology is developing an AI-driven platform to predict and discover bio-signals that may occur during long-term space activities.</p><p>Myelin-H is developing a remote monitoring and diagnostic system for neurological disease using FDA-certified neural sensors and AI-based analysis software.</p><p>Nano PharmaSolutions aims to increase the bioavailability of insoluble drugs and diversify drug intake methods by increasing drug solubility through physical vapor deposition (PVD).</p><p>ViBo Health is developing a personalized intelligent health tracker to design individual health predictions by quantifying metabolic information collected with a multi-scanner.</p><p>Xtory is creating a platform using extended reality (XR) and interactive devices to improve and monitor mental health in stressful, psychologically challenging environments.</p><p>Selected teams will receive an equity investment of USD 100K and admission into an accelerator program that will help them bring their ideas to fruition from various companies and organizations participating in the CIS Challenge. Through this program, each team will research and develop their projects and benefit from an extensive network of global aerospace industry leaders who will support them with academic advice and development expertise.</p><p>The CIS Challenge accelerator program started in September and will run for 13 weeks. Each team will present feasible and concrete details to investors worldwide on Demo Day in early December.</p>
list